EDMOND DE ROTHSCHILD HOLDING S.A. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$81,488
+0.9%
8000.0%0.00%0.0%
Q2 2023$80,728
+9.7%
8000.0%0.00%0.0%
Q1 2023$73,600
-53.4%
800
-54.1%
0.00%
-50.0%
Q4 2022$158,034
-10.7%
1,742
-25.2%
0.00%
-20.0%
Q3 2022$177,000
-13.7%
2,328
-4.0%
0.01%0.0%
Q2 2022$205,000
-24.9%
2,425
-22.1%
0.01%
-16.7%
Q1 2022$273,000
+11.0%
3,113
+10.5%
0.01%
+20.0%
Q4 2021$246,000
+51.9%
2,817
+41.8%
0.01%
+25.0%
Q3 2021$162,000
+121.9%
1,986
+148.2%
0.00%
+100.0%
Q2 2021$73,000
+7.4%
8000.0%0.00%0.0%
Q1 2021$68,000
-10.5%
8000.0%0.00%
-33.3%
Q4 2020$76,000
+8.6%
8000.0%0.00%0.0%
Q3 2020$70,000
-30.7%
800
-30.4%
0.00%
-25.0%
Q2 2020$101,000
+6.3%
1,1500.0%0.00%
-20.0%
Q1 2020$95,000
-12.8%
1,1500.0%0.01%
+25.0%
Q4 2019$109,000
+55.7%
1,150
+43.8%
0.00%
+33.3%
Q3 2019$70,000
-4.1%
8000.0%0.00%0.0%
Q2 2019$73,000
-5.2%
8000.0%0.00%0.0%
Q1 2019$77,000
+11.6%
8000.0%0.00%
+50.0%
Q4 2018$69,000
-31.0%
800
-31.0%
0.00%
-33.3%
Q3 2018$100,000
+13.6%
1,1600.0%0.00%0.0%
Q2 2018$88,000
-6.4%
1,1600.0%0.00%0.0%
Q1 2018$94,000
-3.1%
1,1600.0%0.00%0.0%
Q4 2017$97,000
-47.3%
1,160
-46.3%
0.00%
-40.0%
Q3 2017$184,000
+89.7%
2,160
+86.2%
0.01%
+66.7%
Q2 2017$97,000
+12.8%
1,1600.0%0.00%
+50.0%
Q1 2017$86,000
+48.3%
1,160
+45.0%
0.00%0.0%
Q4 2016$58,0008000.00%
Other shareholders
NOVARTIS A G shareholders Q4 2016
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders